secwatch.observer — SEC 8-K summary
======================================

Issuer:     Silo Pharma, Inc. (SILO)
CIK:        0001514183
Form:       8-K
Filed at:   2026-08-19T21:17:23+00:00
Accession:  0001213900-26-091783
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.40
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Silo Pharma acquires software assets for 165k shares; seller is affiliate advisor
--------------------------------------------------------------------------------

- Asset purchase agreement dated Aug 18, 2026 with Parkview Consulting LLC; consideration is 165,000 common shares (par $0.0001).
- Assets include software "Reputation Endpoints" with full source/object code and related IP; seller is Corwin Yu, lead strategic advisor on Silo's Crypto Advisory Board.
- Shares subject to 12-month lock-up, ending earlier on change of control or company consent; sale exempt under Section 4(a)(2).
- Seller indemnifies for misrepresentation, IP infringement, gross negligence/fraud; reps survive 12 months.
- Agreement governed by New York law; transaction closed effective August 18, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1514183/000121390026091783/0001213900-26-091783-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1514183/000121390026091783/ea0302618-8k_silo.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-091783

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer